The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.
The invention also relates to the therapeutic use of such thiazole compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.
本发明涉及一种化合物,其为公式I和公式II的
噻唑化合物,以及其组合物,可用于治疗由蛋白激酶B(PKB)介导的疾病,其中变量具有本文中提供的定义。本发明还涉及在治疗异常细胞生长、癌症、炎症和代谢紊乱等疾病状态中使用这种
噻唑化合物和其组合物的治疗用途。